The Oncology Institute, Inc. (TOI)
Provides cancer treatment services including infusions, pharmacy, and clinical trials.
$4.95-0.05%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+32.7%
The outlook
TOI trades at $4.95, sitting roughly midway in its 52-week range with mixed momentum against its moving averages. Analyst coverage leans bullish, with the average price target implying significant upside from current levels. The overall data reflects cautious optimism, though near-term price direction remains uncertain.
What’s behind the score
Price trendMixed vs its moving averages
52-week range60% of the way from its 52-week low to high
Price targetAvg target +70% vs current price
Analyst price target
~12-month · 5 analysts$8.40average target+69.7% vs now
Now $4.95
Low $7.00High $10.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$494.9M
52-wk high
$6.67
52-wk low
$2.32
50-day avg
$5.09
200-day avg
$3.84
Trailing P/E
—